[
  {
    "ts": "2026-01-30T10:04:00+00:00",
    "headline": "Should You Buy Guardant Health Before Feb. 19?",
    "summary": "This genomics stock appears to be at an inflection point.",
    "url": "https://www.fool.com/investing/2026/01/30/should-you-buy-guardant-health-before-feb-19/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "078f922b-2bcf-3a1d-b035-08f6b42fad9a",
      "content": {
        "id": "078f922b-2bcf-3a1d-b035-08f6b42fad9a",
        "contentType": "STORY",
        "title": "Should You Buy Guardant Health Before Feb. 19?",
        "description": "",
        "summary": "This genomics stock appears to be at an inflection point.",
        "pubDate": "2026-01-30T10:04:00Z",
        "displayTime": "2026-01-30T10:04:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/e6177492c07073a15d5b5a164a726b74",
          "originalWidth": 1400,
          "originalHeight": 787,
          "caption": "A clock displaying \"time to buy.\"",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rnQW4.TnB3jLYHPtHdqpww--~B/aD03ODc7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/e6177492c07073a15d5b5a164a726b74.cf.webp",
              "width": 1400,
              "height": 787,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/bRLi3zb3HraujR3SYcHYGQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/e6177492c07073a15d5b5a164a726b74.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/30/should-you-buy-guardant-health-before-feb-19/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-guardant-health-feb-19-100400688.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GH"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T08:51:29+00:00",
    "headline": "Heard on the Street Thursday Recap: Gold Swings",
    "summary": "Gold prices went haywire. A 9.4 percentage point swing in gold futures prices between the intraday high and low was the largest range since April 2013, according to Dow Jones Market Data. Futures settled slightly up on the day, at a new record high.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-30-2026/card/heard-on-the-street-thursday-recap-gold-swings-53wWUalGb8kPyDkNgfCo?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "9e49bb7e-fbf6-38c0-8cdc-21667deadca9",
      "content": {
        "id": "9e49bb7e-fbf6-38c0-8cdc-21667deadca9",
        "contentType": "STORY",
        "title": "Heard on the Street Thursday Recap: Gold Swings",
        "description": "",
        "summary": "Gold prices went haywire. A 9.4 percentage point swing in gold futures prices between the intraday high and low was the largest range since April 2013, according to Dow Jones Market Data. Futures settled slightly up on the day, at a new record high.",
        "pubDate": "2026-01-30T08:51:29Z",
        "displayTime": "2026-01-30T08:51:29Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/9e49bb7e-fbf6-38c0-8cdc-21667deadca9/heard-on-the-street-thursday.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-30-2026/card/heard-on-the-street-thursday-recap-gold-swings-53wWUalGb8kPyDkNgfCo?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GC=F"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "CL=F"
            },
            {
              "symbol": "META"
            },
            {
              "symbol": "IBM"
            },
            {
              "symbol": "HON"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T12:50:00+00:00",
    "headline": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
    "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
    "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "be49aea0-3735-3948-bc45-d360e9bf96cd",
      "content": {
        "id": "be49aea0-3735-3948-bc45-d360e9bf96cd",
        "contentType": "STORY",
        "title": "Buy, Sell or Hold MRK Stock: Key Factors to Watch Before Q4 Earnings",
        "description": "",
        "summary": "Merck heads into Q4 earnings with strong Keytruda demand and new product launches, but declining estimates and M&A costs cloud the near-term outlook.",
        "pubDate": "2026-01-30T12:50:00Z",
        "displayTime": "2026-01-30T12:50:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/huVQAxApMqB.EnhvDFmmKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AOhBEAisdCF50xeLb4f6kA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/7813b4a575be05490cc210e943a2c6f1.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-sell-hold-mrk-stock-125000821.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "CDTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T13:49:00+00:00",
    "headline": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
    "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
    "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "9f8b8207-24f5-3073-a233-63f5d7e108fd",
      "content": {
        "id": "9f8b8207-24f5-3073-a233-63f5d7e108fd",
        "contentType": "STORY",
        "title": "Will BMY's Oncology Collaborations Drive Its Next Growth Phase?",
        "description": "",
        "summary": "BMY boosts its oncology pipeline with a Janux deal on tumor-activated therapy, alongside encouraging pumitamig data and multiple cancer collaborations.",
        "pubDate": "2026-01-30T13:49:00Z",
        "displayTime": "2026-01-30T13:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AZ1NFKr1Arip4UWINeWStw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zL5_evNVQm1N5N.bc6WldQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/52b6d392b63705aefb517365eab38a95.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bmys-oncology-collaborations-drive-next-134900674.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JANX"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "BMY"
            },
            {
              "symbol": "MSFT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T16:08:24+00:00",
    "headline": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push",
    "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
    "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "c713a3ef-d331-31a2-99ba-4714b7489071",
      "content": {
        "id": "c713a3ef-d331-31a2-99ba-4714b7489071",
        "contentType": "STORY",
        "title": "Eli Lilly to build $3.5 billion Pennsylvania plant in US manufacturing push ",
        "description": "",
        "summary": "WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical manufacturing facility in Pennsylvania, its fourth new site in an effort to expand U.S. production and",
        "pubDate": "2026-01-30T16:08:24Z",
        "displayTime": "2026-01-30T16:08:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020.   REUTERS/Mike Blake/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MKiT0fyZ2nkT.Au0ZZjn_w--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nFw48OXamu8W4xPWAnKMHg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/a88ecd38953893af426480199a607e70.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-build-3-5-160649482.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "MRK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T17:36:55+00:00",
    "headline": "This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth",
    "summary": "With the tech sector coming under pressure many are looking for alternative investment areas. This pharma stock is an option worth considering.",
    "url": "https://www.investors.com/stock-lists/stock-spotlight/ligand-pharmaceuticals-lgnd-eyes-entries-battles-key-level-earnings-growth/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "6568c1f4-c293-3cb4-bdc6-b090b8978ef0",
      "content": {
        "id": "6568c1f4-c293-3cb4-bdc6-b090b8978ef0",
        "contentType": "STORY",
        "title": "This Pharma Stock Eyes Entries, Battles For Key Level Amid 68% Earnings Growth",
        "description": "",
        "summary": "With the tech sector coming under pressure many are looking for alternative investment areas. This pharma stock is an option worth considering.",
        "pubDate": "2026-01-30T17:36:55Z",
        "displayTime": "2026-01-30T17:36:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/6568c1f4-c293-3cb4-bdc6-b090b8978ef0/this-pharma-stock-eyes.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/176afa6bfa0657f892507bdf9fa9ada6",
          "originalWidth": 1000,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jWWOaJSpIj1OdEb1shAfZQ--~B/aD01NjU7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/176afa6bfa0657f892507bdf9fa9ada6.cf.webp",
              "width": 1000,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kgFv6iXdYyEHVPIARMzrOw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/176afa6bfa0657f892507bdf9fa9ada6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/stock-lists/stock-spotlight/ligand-pharmaceuticals-lgnd-eyes-entries-battles-key-level-earnings-growth/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LGND"
            },
            {
              "symbol": "LGNDZ"
            },
            {
              "symbol": "LGNXZ"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JAZZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T14:41:06+00:00",
    "headline": "Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish?",
    "summary": "Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
    "url": "https://www.barchart.com/story/news/37322875/merck-co-stock-outlook-is-wall-street-bullish-or-bearish",
    "source": "Barchart",
    "provider": "yfinance",
    "raw": {
      "id": "4de2c167-e38e-33ce-9bab-39e53ec58f4a",
      "content": {
        "id": "4de2c167-e38e-33ce-9bab-39e53ec58f4a",
        "contentType": "STORY",
        "title": "Merck & Co. Stock Outlook: Is Wall Street Bullish or Bearish?",
        "description": "",
        "summary": "Merck & Co. has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.",
        "pubDate": "2026-01-30T14:41:06Z",
        "displayTime": "2026-01-30T14:41:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/barchart_com_477/37f1ca4d5fbb275ba80b4077f1cd015f",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Merck & Co Inc logo and pill-by viewimage via Shutterstock",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rXu.b0M5XojHEgR9ZEpmbA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/barchart_com_477/37f1ca4d5fbb275ba80b4077f1cd015f.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mpTDF4NNZEOyilk0MsYuQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/barchart_com_477/37f1ca4d5fbb275ba80b4077f1cd015f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barchart",
          "url": "https://www.barchart.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barchart.com/story/news/37322875/merck-co-stock-outlook-is-wall-street-bullish-or-bearish",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-co-stock-outlook-wall-144106451.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T23:18:28+00:00",
    "headline": "Merck Reshapes Oncology Strategy With Partnerships While Shares Screen As Undervalued",
    "summary": "Merck (NYSE:MRK) has ended acquisition talks with Revolution Medicines after the parties could not agree on valuation. The company is investing $30 million in Eikon Therapeutics ahead of Eikon's planned IPO. Merck has also entered a multi year global oncology collaboration with Guardant Health focused on companion diagnostics and cancer therapies. Merck, trading at $110.27, has seen its share price move 15.8% over the past year and 78.8% over the past five years. Returns of 1.9% over the...",
    "url": "https://finance.yahoo.com/news/merck-reshapes-oncology-strategy-partnerships-231828717.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "28a6bbfb-7b8e-34fd-803e-d1cd933326ff",
      "content": {
        "id": "28a6bbfb-7b8e-34fd-803e-d1cd933326ff",
        "contentType": "STORY",
        "title": "Merck Reshapes Oncology Strategy With Partnerships While Shares Screen As Undervalued",
        "description": "",
        "summary": "Merck (NYSE:MRK) has ended acquisition talks with Revolution Medicines after the parties could not agree on valuation. The company is investing $30 million in Eikon Therapeutics ahead of Eikon's planned IPO. Merck has also entered a multi year global oncology collaboration with Guardant Health focused on companion diagnostics and cancer therapies. Merck, trading at $110.27, has seen its share price move 15.8% over the past year and 78.8% over the past five years. Returns of 1.9% over the...",
        "pubDate": "2026-01-30T23:18:28Z",
        "displayTime": "2026-01-30T23:18:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kA84g.s9IO2ClCgTX6BCgg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DmY770n7xz5DXLM6ZHLmxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/d7ea461ebd942c5c61a3f68254dc45cf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-reshapes-oncology-strategy-partnerships-231828717.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-reshapes-oncology-strategy-partnerships-231828717.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "GH"
            },
            {
              "symbol": "RVMD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-30T21:57:51+00:00",
    "headline": "Jobs Report, More Tech Earnings: What to Watch Next Week",
    "summary": "Earnings season marches on next week. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that sent software stocks tumbling.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-30-2026/card/jobs-report-more-tech-earnings-what-to-watch-next-week-RImjk4BbX7ZQ2IQI0whO?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "a1b8ab2d-bdef-312a-be43-2e45c91276a7",
      "content": {
        "id": "a1b8ab2d-bdef-312a-be43-2e45c91276a7",
        "contentType": "STORY",
        "title": "Jobs Report, More Tech Earnings: What to Watch Next Week",
        "description": "",
        "summary": "Earnings season marches on next week. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that sent software stocks tumbling.",
        "pubDate": "2026-01-30T21:57:51Z",
        "displayTime": "2026-01-30T21:57:51Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a1b8ab2d-bdef-312a-be43-2e45c91276a7/jobs-report-more-tech.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/cf6a54be63658dfd69d6c7ba035c59ea",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SZUiVZZ42KpjrK_ZQ3c.Ng--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/cf6a54be63658dfd69d6c7ba035c59ea.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/FKUglArkR9ZcBRUnP.OtQQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/cf6a54be63658dfd69d6c7ba035c59ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-01-30-2026/card/jobs-report-more-tech-earnings-what-to-watch-next-week-RImjk4BbX7ZQ2IQI0whO?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "DIS"
            },
            {
              "symbol": "TSN"
            },
            {
              "symbol": "NXPI"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "NVS"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "MDLZ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]